Annual FCF:
-$69.31M-$44.37M(-177.92%)Summary
- As of today, SLNO annual free cash flow is -$69.31 million, with the most recent change of -$44.37 million (-177.92%) on December 31, 2024.
- During the last 3 years, SLNO annual free cash flow has fallen by -$41.52 million (-149.40%).
- SLNO annual free cash flow is now -7718.84% below its all-time high of -$886.50 thousand, reached on December 31, 2013.
Performance
SLNO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$12.62M+$20.14M(+61.48%)Summary
- As of today, SLNO quarterly free cash flow is -$12.62 million, with the most recent change of +$20.14 million (+61.48%) on June 30, 2025.
- Over the past year, SLNO quarterly free cash flow has increased by +$5.04 million (+28.55%).
- SLNO quarterly free cash flow is now -705.54% below its all-time high of $2.08 million, reached on March 31, 2013.
Performance
SLNO Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$84.49M+$5.04M(+5.63%)Summary
- As of today, SLNO TTM free cash flow is -$84.49 million, with the most recent change of +$5.04 million (+5.63%) on June 30, 2025.
- Over the past year, SLNO TTM free cash flow has dropped by -$41.65 million (-97.20%).
- SLNO TTM free cash flow is now -4155.00% below its all-time high of $2.08 million, reached on March 31, 2013.
Performance
SLNO TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SLNO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -177.9% | +28.6% | -97.2% |
| 3Y3 Years | -149.4% | -172.7% | -263.0% |
| 5Y5 Years | -298.4% | -93.1% | -260.4% |
SLNO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -233.3% | at low | -171.0% | +61.5% | -306.3% | +5.6% |
| 5Y | 5-Year | -298.4% | at low | -172.7% | +61.5% | -306.3% | +5.6% |
| All-Time | All-Time | -7718.8% | at low | -705.5% | +61.5% | -4155.0% | +5.6% |
SLNO Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$12.62M(+61.5%) | -$84.49M(+5.6%) |
| Mar 2025 | - | -$32.76M(-36.5%) | -$89.53M(-29.2%) |
| Dec 2024 | -$69.31M(-177.9%) | -$24.00M(-58.8%) | -$69.31M(-34.3%) |
| Sep 2024 | - | -$15.12M(+14.4%) | -$51.63M(-20.5%) |
| Jun 2024 | - | -$17.66M(-40.8%) | -$42.84M(-39.3%) |
| Mar 2024 | - | -$12.54M(-98.6%) | -$30.75M(-23.3%) |
| Dec 2023 | -$24.94M(-19.9%) | -$6.31M(+0.3%) | -$24.94M(-4.9%) |
| Sep 2023 | - | -$6.33M(-13.8%) | -$23.77M(-7.6%) |
| Jun 2023 | - | -$5.57M(+17.3%) | -$22.10M(-4.4%) |
| Mar 2023 | - | -$6.73M(-30.7%) | -$21.16M(-1.8%) |
| Dec 2022 | -$20.79M(+25.2%) | -$5.15M(-10.6%) | -$20.79M(+7.7%) |
| Sep 2022 | - | -$4.66M(-0.6%) | -$22.52M(+3.2%) |
| Jun 2022 | - | -$4.63M(+27.3%) | -$23.28M(+12.7%) |
| Mar 2022 | - | -$6.36M(+7.5%) | -$26.66M(+4.1%) |
| Dec 2021 | -$27.79M(-10.2%) | -$6.88M(-27.1%) | -$27.79M(-0.0%) |
| Sep 2021 | - | -$5.41M(+32.5%) | -$27.79M(+2.6%) |
| Jun 2021 | - | -$8.01M(-7.0%) | -$28.54M(-5.5%) |
| Mar 2021 | - | -$7.49M(-9.0%) | -$27.06M(-7.3%) |
| Dec 2020 | -$25.23M(-45.0%) | -$6.87M(-11.4%) | -$25.23M(-7.6%) |
| Sep 2020 | - | -$6.17M(+5.6%) | -$23.44M(-6.6%) |
| Jun 2020 | - | -$6.53M(-15.5%) | -$21.99M(-13.6%) |
| Mar 2020 | - | -$5.66M(-11.4%) | -$19.36M(-11.3%) |
| Dec 2019 | -$17.40M | -$5.08M(-7.7%) | -$17.40M(-8.4%) |
| Sep 2019 | - | -$4.72M(-21.0%) | -$16.05M(-14.5%) |
| Jun 2019 | - | -$3.90M(-5.5%) | -$14.02M(-8.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$3.70M(+1.1%) | -$12.87M(-10.1%) |
| Dec 2018 | -$11.69M(-17.5%) | -$3.74M(-39.4%) | -$11.69M(-9.4%) |
| Sep 2018 | - | -$2.68M(+2.5%) | -$10.68M(-6.4%) |
| Jun 2018 | - | -$2.75M(-9.2%) | -$10.04M(+2.4%) |
| Mar 2018 | - | -$2.52M(+7.7%) | -$10.29M(-3.4%) |
| Dec 2017 | -$9.95M(+26.4%) | -$2.73M(-33.6%) | -$9.95M(-0.5%) |
| Sep 2017 | - | -$2.04M(+31.8%) | -$9.90M(+7.0%) |
| Jun 2017 | - | -$3.00M(-37.2%) | -$10.65M(+8.9%) |
| Mar 2017 | - | -$2.18M(+18.6%) | -$11.69M(+13.5%) |
| Dec 2016 | -$13.51M(-27.4%) | -$2.68M(+3.8%) | -$13.51M(+5.6%) |
| Sep 2016 | - | -$2.79M(+31.0%) | -$14.32M(+1.7%) |
| Jun 2016 | - | -$4.04M(-0.9%) | -$14.57M(-13.9%) |
| Mar 2016 | - | -$4.00M(-14.8%) | -$12.80M(-20.7%) |
| Dec 2015 | -$10.61M(-134.9%) | -$3.49M(-14.6%) | -$10.61M(-21.8%) |
| Sep 2015 | - | -$3.04M(-34.3%) | -$8.71M(-25.8%) |
| Jun 2015 | - | -$2.27M(-25.2%) | -$6.92M(-19.0%) |
| Mar 2015 | - | -$1.81M(-14.1%) | -$5.82M(-28.8%) |
| Dec 2014 | -$4.51M(-409.3%) | -$1.59M(-26.2%) | -$4.51M(-23.7%) |
| Sep 2014 | - | -$1.26M(-8.4%) | -$3.65M(-52.6%) |
| Jun 2014 | - | -$1.16M(-128.1%) | -$2.39M(+6.3%) |
| Mar 2014 | - | -$509.00K(+29.6%) | -$2.55M(-6716.6%) |
| Dec 2013 | -$886.50K(+74.7%) | -$722.50K(+45.4%) | $38.60K(-94.9%) |
| Jun 2013 | - | -$1.32M(-163.5%) | $761.10K(-63.5%) |
| Mar 2013 | - | $2.08M | $2.08M |
| Dec 2012 | -$3.50M | - | - |
FAQ
- What is Soleno Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Soleno Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Soleno Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Soleno Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of SLNO is -$69.31M
What is the all-time high annual free cash flow for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high annual free cash flow is -$886.50K
What is Soleno Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, SLNO annual free cash flow has changed by -$44.37M (-177.92%)
What is Soleno Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of SLNO is -$12.62M
What is the all-time high quarterly free cash flow for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high quarterly free cash flow is $2.08M
What is Soleno Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, SLNO quarterly free cash flow has changed by +$5.04M (+28.55%)
What is Soleno Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of SLNO is -$84.49M
What is the all-time high TTM free cash flow for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high TTM free cash flow is $2.08M
What is Soleno Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, SLNO TTM free cash flow has changed by -$41.65M (-97.20%)